ReviewJournal of dental sciences2025
Boosting the antibacterial potency of antimicrobial photodynamic therapy against oral pathogens through supplement agents: A narrative review.
Review in Journal of dental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Resveratrol-loaded human dental pulp stem cell-derived exosomes enhance the efficacy of blue LED-mediated antimicrobial photodynamic therapy against mature cariogenic biofilms.Lasers in medical science · 2026Article
- Strategies to Enhance the Efficacy and Clinical Translation of Antimicrobial Photodynamic Therapy.Antibiotics (Basel, Switzerland) · 2026Review
- Influence of porphyrin cationic charges on photoinactivation of Candida albicans morphotypes.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial photodynamic therapy (aPDT) is a promising approach for managing oral infections; however, it faces several limitations, such as limited penetration depth, biofilm resistance, and photosensitizer dimerization or aggregation. To address these challenges, the current study reviews new techniques to enhance the antibacterial effectiveness of aPDT. Recent advances have pointed out the potential of novel supplement agents-including inorganic salts, antimicrobial peptides, surfactant media, and postbiotics-to overcome these limitations significantly. Inorganic salts like potassium iodide, potassium selenocyanate, and potassium thiocyanate can enhance aPDT by generating additional reactive species or increasing reactive oxygen species (ROS)-mediated cytotoxicity. Antimicrobial peptides disrupt membranes selectively and help penetrate deeper into biofilms, while surfactant media improve the solubility of photosensitizers and prevent their aggregation, thereby maximizing ROS production. Postbiotics not only lead to improved biofilm penetration but also cause increased oxidative stress on microbial cells. Therefore, these combined strategies have markedly improved microbial eradication, particularly against resilient biofilms and antibiotic-resistant strains. Although integrating these innovative supplement agents signals a new era for photodynamic therapy in oral healthcare-presenting renewed opportunities for practical, non-invasive, and resistance-free infection control-further studies are necessary to validate these findings, establish standardized protocols, and evaluate the long-term safety and clinical benefits of these combined strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.